fitbit
Auto Added by WPeMatico
Tile secures $40 million to take on Apple AirTag with new products
Tile, the maker of Bluetooth-powered lost item finder beacons and, more recently, a staunch Apple critic, announced today it has raised $40 million in non-dilutive debt financing from Capital IP. The funding will be put toward investment in Tile’s finding technologies, ahead of the company’s plan to unveil a new slate of products and features that the company believes will help it to better compete with Apple’s AirTags and further expand its market.
The company has been a longtime leader in the lost item finder space, offering consumers small devices they can attach to items — like handbags, luggage, bikes, wallets, keys and more — which can then be tracked using the Tile smartphone app for iOS or Android. When items go missing, the Tile app leverages Bluetooth to find the items and can make them play a sound. If the items are further afield, Tile taps into its broader finding network consisting of everyone who has the app installed on their phone and other access points. Through this network, Tile is able to automatically and anonymously communicate the lost item’s location back to its owner through their own Tile app.
Image Credits: Tile
Tile has also formed partnerships focused on integrating its finding network into over 40 different third-party devices, including those across audio, travel, wearables and PC categories. Notable brand partners include HP, Dell, Fitbit, Skullcandy, Away, Xfinity, Plantronics, Sennheiser, Bose, Intel and others. Tile says it’s seen 200% year-over-year growth on activations of these devices with its service embedded.
To date, Tile has sold more than 40 million devices and has over 425,000 paying customers — a metric it’s revealing for the first time. It doesn’t disclose its total number of users, both free and paid combined, however. During the first half of 2021, Tile says revenues increased by over 50%, but didn’t provide hard numbers.
While Tile admits that the COVID-19 pandemic had some impacts on international expansions, as some markets have been slower to rebound, it has still seen strong performance outside the U.S., and considers that a continued focus.
The pandemic, however, hasn’t been Tile’s only speed bump.
When Apple announced its plans to compete with the launch of AirTags, Tile went on record to call it unfair competition. Unlike Tile devices, Apple’s products could tap into the iPhone’s U1 chip to allow for more accurate finding through the use of ultra-wideband technologies available on newer iPhone models. Tile, meanwhile, has plans for its own ultra-wideband-powered device, but hadn’t been provided the same access. In other words, Apple gave its own lost item finder early, exclusive access to a feature that would allow it to differentiate itself from the competition. (Apple has since announced it’s making ultra-wideband APIs available to third-party developers, but this access wasn’t available from day one of AirTag’s arrival.)
Image Credits: Tile internal concept art
Tile has been vocal on the matter of Apple’s anti-competitive behavior, having testified in multiple congressional hearings alongside other Apple critics, like Spotify and Match. As a result of increased regulatory pressure, Apple later opened up its Find My network to third-party devices, in an effort to placate Tile and the other rivals its AirTags would disadvantage.
But Tile doesn’t want to route its customers to Apple’s first-party app — it intends to use its own app in order to compete based on its proprietary features and services. Among other things, this includes Tile’s subscriptions. A base plan is $29.99 per year, offering features like free battery replacement, smart alerts and location history. A $99.99 per year plan also adds insurance of sorts — it pays up to $1,000 per year for items it can’t find. (AirTag doesn’t do that.)
Despite its many differentiators, Tile faces steep competition from the ultra-wideband-capable AirTags, which have the advantage of tapping into Apple’s own finding network of potentially hundreds of millions of iPhone owners.
However, Tile CEO CJ Prober — who joined the company in 2018 — claims AirTag hasn’t impacted the company’s revenue or device sales.
“But that doesn’t take away from the fact that they’re making things harder for us,” he says of Apple. “We’re a growing business. We’re winning the hearts and minds of consumers… and they’re competing unfairly.”
“When you own the platform, you shouldn’t be able to identify a category that you want to enter, disadvantage the incumbents in that category, and then advantage yourself — like they did in our case,” he adds.
Tile is preparing to announce an upcoming product refresh that may allow it to better take on the AirTag. Presumably, this will include the pre-announced ultra-wideband version of Tile, but the company says full details will be shared next week. Tile may also expand its lineup in other ways that will allow it to better compete based on look and feel, size and shape, and functionality.
Tile’s last round of funding was $45 million in growth equity in 2019. Now it’s shifted to debt. In addition to new debt financing, Tile is also refinancing some of its existing debt with this fundraise, it says.
“My philosophy is it’s always good to have a mix of debt and equity. So some amount of debt on the balance sheet is good. And it doesn’t incur dilution to our shareholders,” Prober says. “We felt this was the right mix of capital choice for us.”
The company chose to work with Capital IP, a group it’s had a relationship with over the last three years, and who Tile had considered bringing on as an investor. The group has remained interested in Tile and excited about its trajectory, Prober notes.
“We are excited to partner with the Tile team as they continue to define and lead the finding category through hardware and software-based innovations,” said Capital IP’s Managing Partner Riyad Shahjahan, in a statement. “The impressive revenue growth and fast-climbing subscriber trends underline the value proposition that Tile delivers in a platform-agnostic manner, and were a critical driver in our decision to invest. The Tile team has an ambitious roadmap ahead and we look forward to supporting their entry into new markets and applications to further cement their market leadership,” he added.
Powered by WPeMatico
Compete in Startup Battlefield and Launch at Disrupt SF 2020
Early-stage founders: Don’t miss your chance to follow in the footsteps of tech giants. We know COVID-19 has created challenges for startup founders, but fear not. Disrupt SF is still proceeding as scheduled, with a Disrupt Digital Pass Virtual option. Launch your startup in the world’s most famous pitch competition, Startup Battlefield. The smackdown goes down live on the Main Stage at Disrupt San Francisco 2020 on September 14-16. Want a shot at $100,000 and the Disrupt Cup? Fill out your application to compete right here.
Companies such as Fitbit, Cloudflare, Mint.com, Dropbox, Vurb, Yammer and Getaround — to name but a few — trace their origins to the Battlefield competition. The Startup Battlefield Alumni Community — 902 companies strong and counting — has collectively raised $9 billion and produced more than 115 successful exits (IPOs or acquisitions). That’s some impressive company to keep. Why not join their ranks?
Here’s how Startup Battlefield works. First, you apply. (Pro tip: Applying and competing in the Battlefield is free and TechCrunch does not take any equity). Next, TechCrunch’s Battlefield-savvy editorial team pours over every application looking for approximately 20 startups to pitch on the Main Stage.
The TechCrunch team will put all participants through rigorous, weeks-long training to hone pitches, business models, presentation skills and any other startup issues that require tightening. You’ll be in fighting trim and ready to step out onto the Main Stage.
Teams have just six minutes to pitch and present a live demo to a panel of expert judges. After each pitch, the judges (we’re talking folks like Cyan Banister, Kirsten Green, Aileen Lee, Alfred Lin and Roelof Botha) will put each team through a Q&A. No flop-sweat here, thanks to all those weeks of pitch coaching.
The judges will select anywhere from four to six teams to advance to the finals. And that means another pitch and Q&A in front of a fresh set of judges. The winning team takes home $100,000, the coveted Disrupt Cup and they bask in a spotlight of media and investor attention. Startup Battlefield can be a life-changing experience for all competitors — not just the ultimate winner.
The action takes place in front of an enthusiastic audience of thousands. Plus, we live-stream the entire event on TechCrunch.com, once you sign up for the digital pass. If all that’s not enough, consider this. Startup Battlefield competitors receive a VIP Disrupt experience.
You’ll have access to private VIP events like the Startup Battlefield Reception, and each team receives four complimentary event tickets. You get to exhibit at the show for all three days, and you’ll have access to CrunchMatch, TC’s investor-founder networking platform. And you also get a complimentary ticket to all future TC events and free subscriptions to Extra Crunch.
Whew. That’s a whole lot of opportunity and exposure. So, what are you waiting for? Disrupt San Francisco 2020 takes place on September 14-16. Apply to compete in Startup Battlefield for a shot at launching your dream to the world.
TechCrunch is mindful of the COVID-19 issue and its impact on live events. You can follow our updates here.
Is your company interested in sponsoring or exhibiting at Disrupt San Francisco 2020? Contact our sponsorship sales team by filling out this form.
Powered by WPeMatico
Nebia’s co-founder talks about finding product/market fit
Finding the right product/market fit is challenging for any company, but it’s just a little harder for hardware startups.
I recently visited the San Francisco offices of Nebia to chat with co-founder and CEO Philip Winter, whose eco-friendly hardware startup has received funding from Apple CEO Tim Cook, former Google CEO Eric Schmidt and Fitbit CEO James Park. After checking out the company’s latest shower head, we eased into a discussion about the opportunities and challenges facing hardware startups in Silicon Valley today.
TechCrunch: What’s so hard about hardware in 2020?
Philip Winter: The hardware landscape was, at one point, super-hot, at least in Silicon Valley. I would say like three or four years ago. A lot of companies came out with breakout products and a lot of them disappeared over the years since then. A lot of them are our peers — it’s a fairly small community.
Powered by WPeMatico
No one knows how effective digital therapies are, but a new tool from Elektra Labs aims to change that
Depending on which study you believe, the wearable and digital health market could be worth anywhere from $30 billion to nearly $90 billion in the next six years.
If the numbers around the size of the market are a moving target, just think about how to gauge the validity and efficacy of the products that are behind all of those billions of dollars in spending.
Andy Coravos, the co-founder of Elektra Labs, certainly has.
Coravos, whose parents were a dentist and a nurse practitioner, has been thinking about healthcare for a long time. After a stint in private equity and consulting, she took a coding bootcamp and returned to the world she was raised in by taking an internship with the digital therapeutics company Akili Interactive.
Coravos always thought she wanted to be in healthcare, but there was one thing holding her back, she says. “I’m really bad with blood.”
That’s why digital therapeutics made sense. The stint at Akili led to a position at the U.S. Food and Drug Administration as an entrepreneur in residence, which led to the creation of Elektra Labs roughly two years ago.
Now the company is launching Atlas, which aims to catalog the biometric monitoring technologies that are flooding the consumer health market.
These monitoring technologies, and the applications layered on top of them, have profound implications for consumer health, but there’s been no single place to gauge how effective they are, or whether the suggestions they’re making about how their tools can be used are even valid. Atlas and Elektra are out to change that.
The FDA has been accelerating its clearances for software-driven products like the atrial fibrillation detection algorithm on the Apple Watch and the ActiGraph activity monitors. And big pharma companies like Roche, Pfizer and Novartis have been investing in these technologies to collect digital biomarker data and improve clinical trials.
Connected technologies could provide better care, but the technologies aren’t without risks. Specifically, the accuracy of data and the potential for bias inherent in algorithms that were created using flawed data sets mean there’s a lot of oversight that still needs to be done, and consumers and pharmaceutical companies need to have a source of easily accessible data about the industry.
”The increase in FDA clearances for digital health products coupled with heavy investment in technology has led to accelerated adoption of connected tools in both clinical trials and routine care. However, this adoption has not come without controversy,” said Coravos in a statement. “During my time as an Entrepreneur in Residence in the FDA’s Digital Health Unit, it became clear to me that like pharmacies which review, prepare, and dispense drug components, our healthcare system needs infrastructure to review, prepare, and dispense connected technologies components.”
The analogy to a pharmacy isn’t an exact fit, because Elektra Labs currently doesn’t prepare or dispense any of the treatments that it reviews. But Atlas is clearly the first pillar that the digital therapeutics industry needs as it looks to supplant pharmaceuticals as treatments for some of the largest and most expensive chronic conditions (like diabetes).
Courtesy of Andrea Coravos/Elektra Labs
Coravos and here team interviewed more than 300 professionals as they built the Atlas toolkit for pharmaceutical companies and other healthcare stakeholders seeking a one-stop shop for all their digital healthcare data needs. Like a drug label, or nutrition label, Atlas publishes labels that highlight issues around the usability, validation, utility, security and data governance of a product.
In an article in Quartz earlier this year, Coravos made her pitch for Elektra Labs and the types of things it would monitor for the nascent digital therapeutics industry. It includes the ability to handle adverse events involving digital therapies by providing a single source where problems could be reported; a basic description for consumers of how the products work; an assessment of who should actually receive digital therapies, based on the assessment of how well certain digital products perform with certain users; a description of a digital therapy’s provenance and how it was developed; a database of the potential risks associated with the product; and a record of the product’s security and privacy features.
As the projections on market size show, the problem isn’t going to get any smaller. As Google’s recent acquisition bid for Fitbit and the company’s reported partnership with Ascension on “Project Nightingale” to collect and digitize more patient data shows, the intersection of technology and healthcare is a huge opportunity for technology companies.
“Google is investing more. Apple is investing more… More and more of these devices are getting FDA cleared and they’re becoming not just wellness tools but healthcare tools,” says Coravos of the explosion of digital devices pitching potential health and wellness benefits.
Elektra Labs is already working with undisclosed pharmaceutical companies to map out the digital therapeutic environment and identify companies that might be appropriate partners for clinical trials or acquisition targets in the digital market.
“The FDA is thinking about these digital technologies, but there were a lot of gaps,” says Coravos. And those gaps are what Elektra Labs is designed to fill.
At its core, the company is developing a catalog of the digital biomarkers that modern sensing technologies can track and how effective different products are at providing those measurements. The company is also on the lookout for peer-reviewed published research or any clinical trial data about how effective various digital products are.
Backing Coravos and her vision for the digital pharmacy of the future are venture capital investors, including Maverick Ventures, Arkitekt Ventures, Boost VC, Founder Collective, Lux Capital, SV Angel and Village Global.
Alongside several angel investors, including the founders and chief executives from companies including: PillPack, Flatiron Health, National Vision, Shippo, Revel and Verge Genomics, the venture investors pitched in for a total of $2.9 million in seed funding for Coravos’ latest venture.
“Timing seems right for what Elektra is building,” wrote Brandon Reeves, an investor at Lux Capital, which was one of the first institutional investors in the company. “We have seen the zeitgeist around privacy data in applications on mobile phones and now starting to have the convo in the public domain about our most sensitive data (health).”
If the validation of efficacy is one key tenet of the Atlas platform, then security is the other big emphasis of the company’s digital therapeutic assessment. Indeed, Coravos believes that the two go hand-in-hand. As privacy issues proliferate across the internet, Coravos believes that the same troubles are exponentially compounded by internet-connected devices that are monitoring the most sensitive information that a person has — their own health records.
In an article for Wired, Koravos wrote:
Our healthcare system has strong protections for patients’ biospecimens, like blood or genomic data, but what about our digital specimens? Due to an increase in biometric surveillance from digital tools—which can recognize our face, gait, speech, and behavioral patterns—data rights and governance become critical. Terms of service that gain user consent one time, upon sign-up, are no longer sufficient. We need better social contracts that have informed consent baked into the products themselves and can be adjusted as user preferences change over time.
We need to ensure that the industry has strong ethical underpinning as it brings these monitoring and surveillance tools into the mainstream. Inspired by the Hippocratic Oath—a symbolic promise to provide care in the best interest of patients—a number of security researchers have drafted a new version for Connected Medical Devices.
With more effective regulations, increased commercial activity, and strong governance, software-driven medical products are poised to change healthcare delivery. At this rate, apps and algorithms have the opportunity to augment doctors and complement—or even replace—drugs sooner than we think.
Powered by WPeMatico
CFIUS Cometh: What this obscure agency does and why it matters to your fund or startup
Evan J. Zimmerman
Contributor
Contributor
Evan J. Zimmerman is an entrepreneur, investor, and writer. He is the Chairman of Jovono and Chairman of the Clinton Health Access Initiative technology council. He is a partner and director in Mighty Mug/Mighty Products, Inc, and chairman of Brush Up Club, an innovative oral health company.
On January 12, 2016, Grindr announced it had sold a 60% controlling stake in the company to Beijing Kunlun Tech, a Chinese gaming firm, valuing the company at $155 million. Champagne bottles were surely popped at the small-ish firm.
Though not at a unicorn-level valuation, the 9-figure exit was still respectable and signaled a bright future for the gay hookup app. Indeed, two years later, Kunlun bought the rest of the firm at more than double the valuation and was planning a public offering for Grindr.
On March 27, 2019, it all fell apart. Kunlun was putting Grindr up for sale instead.
What went wrong? It wasn’t that Grindr’s business ground to a halt. By all accounts, its business seems to actually be growing. The problem was that Kunlun owning Grindr was viewed as a threat to national security. Consequently, CFIUS, or the Committee for Foreign Investment in the United States, stepped in to block the transaction.
So what changed? CFIUS was expanded by FIRRMA, or the Foreign Risk Review Modernization Act, in late 2018, which gave it massive new power and scale. Unlike before, FIRRMA gave CFIUS a technology focus. So now CFIUS isn’t just an American problem—it’s an American tech problem. And in the coming years, it will transform venture capital, Chinese involvement in US tech, and maybe even startups as we know it.
Here’s a closer look at how it all fits together.
What is CFIUS?
Image via Getty Images / Busà Photography
CFIUS is the most important agency you’ve never heard of, and until recently it wasn’t even more than a committee. In essence, CFIUS has the ability to stop foreign entities, called “covered entities,” from acquiring companies when it could adversely affect national security—a “covered transaction.”
Once a filing is made, CFIUS investigates the transaction and both parties, which can take over a month in its first pass. From there, the company and CFIUS enter a negotiation to see if they can resolve any issues.
Powered by WPeMatico
Acting as the data integrator between hospitals and digital health apps brings Redox $33 million
Investors have forked over $33 million in a new round of funding for Redox, hoping that the company can execute on its bid to serve as the link between healthcare providers and the technology companies bringing new digital services to market.
The financing comes just two months after Redox sealed a deal with Microsoft to act as the integration partner connecting Microsoft’s Teams product to electronic health records through the Fast Healthcare Interoperability Resources standard.
Redox sits at a critically important crossroads in the modern healthcare industry. Its founder, a former employee at the electronic health record software provider Epic, knows more than most about the central position that data occupies in U.S. healthcare at the moment.
“What we’re doing, we’re building the platform and connector to help health systems integrate with technologies in the cloud,” says chief executive, Luke Bonney.
Bonney served as a team lead in various divisions at Epic before launching Redox, and the Madison, Wis.-based company was crafted with the challenges other vendors faced when trying to integrate with legacy systems like the health record provider.
“The fundamental problem is helping a large health system use a third-party tool that they want to use,” says Bonney. And the biggest obstacle, he said, is finding a way to organize into a format that application developers can work with the data coming from healthcare providers.
Investors including RRE Ventures, Intermountain Ventures and .406 Ventures joined new investor Battery Ventures in financing the $33 million round. As part of the deal, Battery Ventures general partner Chelsea Stoner will take a seat on the company’s board.
Application developers pay for the number of integrations they have with a health system, and Redox enables them to connect through a standard application programming interface, according to the company.
Its approach allows secure messaging across any format associated with an organization’s electronic health record (EHR), the company said.
Redox works with more than 450 healthcare providers and hundreds of application developers, the company said.
High-profile healthcare networks that work with the company include AdventHealth, Atrium Health, Brigham & Women’s, Clarify Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania and WellStar.
Powered by WPeMatico
Snapchat will power Stories & ads in other apps
Snapchat has found an answer to the revenue problem stemming from its halted growth: it will show its ads in other apps with the launch of Snapchat Ad Kit and the Snapchat Audience Network. And rather than watching as other apps spin up their own knock-off versions of its camera and Stories, it will let apps like Tinder and Houseparty host Stories inside their own products that users can share to from the Snapchat camera with Stories Kit. They’ll both be launching later this year, and developers interested in monetization and engagement help can apply for access.
Snapchat debuted the big new additions to its Snap Kit at its first-ever press event in Los Angeles, the Snap Partner Summit, where it also announced a new augmented reality utility platform called Scan, and its new multiplayer games platform. More than 200 apps have already integrated the privacy-safe Snap Kit that lets users log in to other apps with Snapchat, bring their Bitmoji, view Our Stories content and share stickers back to Snapchat.
But later this year, developers will be able to earn money off of Snap Kit with Ad Kit. Developers will integrate Snapchat’s SDK, and then Snap’s advertisers will be able to extend their ad buys to reach both Snapchat users and non-users in other apps. Snapchat will split the ad revenue with developers, but refused to hint at what the divide will be, as it’s still gauging developer interest. The move is straight out of Facebook’s playbook, essentially copying the functionality and name of Facebook’s Audience Network.
There are still big questions about exactly how Snapchat will reach and track ad views of non-users, and how it will be able to provide brands with the analytics they need while maintaining user privacy. But simply by making Snapchat’s somewhat proprietary vertical video ad units reusable elsewhere, it could prove it has a scale to be worth advertisers’ time. The lack of scale has often scared buyers away from Snapchat. But Snap CEO Evan Spiegel says that “In the United States, Snapchat now reaches nearly 75 percent of all 13 to 34-year-olds, and we reach 90 percent of 13 to 24-year-olds. In fact, we reach more 13 to 24-year-olds than Facebook or Instagram in the United States, the U.K., France, Canada and Australia.”
To keep those users engaged even outside of Snapchat, it’s adding App Stories through Story Kit. Snapchat users will see an option to share to integrated apps after they create a photo or video. Those Stories will then appear in custom places in other apps. You’ll see Snaps injected alongside people’s photos when you’re browsing potential matches in Tinder. You can see what friends on group chat social network Houseparty are doing when they are not on the app. And you can see video recommendations from explorers on AdventureAide.
For now, Snapchat won’t run ads between Stories in other apps, but that’s always a possibility. We’ll have to see how long it takes Instagram and Facebook to try to copy Stories Kit and distribute their own versions to other apps.
Snap also has some other fun new integrations and big-name partnerships. Bitmoji Kit will bring your personalized avatar off your phone and onto Fitbit’s smart watches and Venmo transactions. Netflix will let you share preview images (but not trailers) from its shows to your Snapchat Story. A new publisher-sharing button for the web will let you share articles from The Washington Post and others to your Story.
By colonizing other apps with its experience, Snapchat decreases the need for them to copy it. Instead they get the original, and a lot less development work. And the platform makes your Snapchat account more valuable around the web. These integrations might not grow Snapchat too much, but it could help it keep its existing users happy and squeeze more cash out of them.
Powered by WPeMatico
Sapphire Ventures bets big on esports and entertainment with new $115M fund
Sapphire Ventures, formerly the corporate venture capital arm of SAP, has lassoed $115 million from new limited partners (LPs) to invest at the intersection of tech, sports, media and entertainment.
A majority of the LPs for the new fund, called Sapphire Sport, have ties to the sports industry, from City Football Group, which owns English Premier League team Manchester City, to Adidas, the owners of the Indiana Pacers, New York Jets, San Jose Sharks and Tampa Bay Lightning, among others.
The firm plans to do five to six investments per year, sized between $3 million and $7 million. So far, they’ve deployed capital to five startups: at-home fitness system Tonal, live soccer streaming platform mycujoo, digital sports network Overtime, ticketing and events platform Fevo and gaming studio Phoenix Labs. Sapphire began backing tech startups in 2008; in 2016, the firm closed on $1 billion for its third flagship venture fund.
Sapphire managing director and co-founder Doug Higgins is leading the effort alongside newly tapped partner Michael Spirito, who joined from 21st Century Fox, where he focused on business development and digital media for the Fox Sports-owned Yankees Entertainment and Sports (YES) Network, in September.
Higgins was an investment manager at Intel Capital for four years prior to co-launching Sapphire. Throughout his career, he’s managed the firm’s investments in LinkedIn, DocuSign, Square and more.
“We invest in anything that tech is disrupting,” Higgins told TechCrunch. “We were early investors in Fitbit, so we saw the beginning of digital fitness and how tech can impact the lives of anyone, not just high-performance athletes … We are also investors in Square, TicketFly and Paytm and what we’ve been seeing — the dream as a VC — is these massive markets in the sports, media and digital health world that are getting disrupted by tech.”
Sapphire is betting its traditional and well-established venture platform, coupled with the expertise of leading sports entities on board as LPs, will give it a competitive edge as it targets some of the best emerging sports tech companies.
“We see a lot of FOMO happening in this world, where everyone wants to have a play, but to make the best investment you need to have the widest perspective,” Higgins said. “So if you’re a team owner of a particular football team you are going to make better decisions if you are able to share perspectives with owners of other teams.”
“The best entrepreneurs, the ones we all want to invest in, there’s not a draft, they have to select you,” he added.
Investment in esports and gaming has skyrocketed, surpassing a total of $2.5 billion in VC funding in 2018. According to PitchBook, a handful of startups have already raised a total of $65 million in VC backing this year, including a $10.8 million financing for ReKTGlobal, a provider of esports infrastructure services.
“You can’t ignore the numbers on esports,” Higgins added. “They just continue to grow massively and people who have teenage kids, like myself, [those kids] want to grow up to be the next ninja, not the next Tom Brady .”
Powered by WPeMatico
Spire Health Tags are now on Apple’s shelves
Spire’s Health Tags, the dark and tiny devices you stick on your clothes to gather all sorts of health data from your steps, heartbeat and stress levels is now available at your local Apple Store.
The company started out with a breath tracking device to detect when you are feeling tense and help calm you down. But four years in and its now all about the wearable “tags” you stick on items of clothing like your pants or sports bra.
Yes, yes, there are lots of gadgets out there to gather similar information — the Apple Watch will now even detect if you have a fall or if something is wrong with your heart — but the Spire health tag is nothing like a Fitbit or Apple Watch, according to the company. For one, there’s zero need to charge the device. One tag’s battery will last a year and a half before dying out. They’re also machine washable. You just pick a few outfits and stick a tag on each of them.
Of course a few other startups out there are working on making smart, washable, data-gathering clothes. Enflux makes the clothing and then sews in the motion sensor to tell you if you are lifting correctly. Vitali is a “smart” bra with a built-in sensor to detect stress. Then there’s OmSignal, which makes body-hugging workout clothes that gather “medical-grade biometric data to achieve optimal health.” But these tiny health tags are different in that they allow you to choose the clothes you want to adhere the monitor to.
Like Spire’s first product, the Stone, which earned more than $8 million in sales, according to the company, the tags will also pick up on times of stress and help calm you down through a series of breaths and focus on the app.
“Continuous health data will revolutionize health and wellness globally, but early incarnations have been hampered by poor user experiences and a focus on the hardware over the outcomes that the hardware can create,” Spire’s founder Jonathan Palley said. “By making the device ‘disappear’, we believe Health Tag is the first product to unlock the potential.”
Spire’s Health Tags will be sold in Apple Stores as a three-pack for $130, six-pack for $230 and an eight-pack for $300, with additional pack sizes available on the company’s website.
Powered by WPeMatico
Fitbit is crashing after a pretty rough note from Wall Street
Fitbit shaved off another roughly 10% of its value in trading today after a downgrade from a Wall Street firm, which will once again throw on more skepticism as to whether or not Fitbit can be a viable business in the smartwatch market.
The note came from Morgan Stanley this morning, which said it was “hard to see a floor” for the company. This comes amid an increased push from Apple to position its smartwatch as a health-oriented device through a myriad of updates for its health tools, as well as efforts to actually detach it from your smartphone with its own cellular chip. These kinds of notes often tend to send stocks soaring or tumbling depending on the direction they go in as investors look to better calibrate their positions in the market.
Fitbit is working on its next generation of smartwatches that look to go up against the Apple Watch, including the new Fitbit Versa, which my colleague Brian Heater said was the watch “the smartwatch the Ionic should have been” (Fitbit’s first foray into the smartwatch ecosystem, which was a bust). The company is also working on a fitness tracker for kids, and appears to be still doubling down on that health aspect of its wearables that first made it a popular choice among consumers in the first place. Fitbit also bought Twine, a cloud-based health management platform, in February.
Here’s another one of the rough excerpts from the note published by CNBC: “We think new smartwatches will be outweighed by declines in legacy products, while software opportunities in health coaching will take time to ramp.”
Fitbit made its name as a fitness tracker, but Apple increasingly has come out pitching itself not only as a fitness tracker, but one with a robust toolkit for health in general. In addition to a heart monitor, Apple has the ability to create a whole health software ecosystem tied directly into the iPhone, which apps like MyFitnessPal and others can use for data. So Apple will clearly be the biggest hurdle for Fitbit as it looks to figure out what its next-generation fitness wearable looks like, especially as Apple if Apple looks to continue to drop the price of the Apple Watch.
Powered by WPeMatico